[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fxLN3MUwXCdr5RPjwZYIDpOj8CHyjOmngWTgoKXPtZbg":3,"$f820uEWza0tUR6IoqInOpEU3f7h6Evyiab759eGOoeiE":32,"$f3Ft0rKFJHppdzE-vuveecxx1BUcg9iOlMLtyzf_MJDg":57},[4,8,12,16,20,24,28],{"title":5,"slug":6,"path":7},"About Microbeonline.com","about-microbeonline-com","\u002Fabout-microbeonline-com\u002F",{"title":9,"slug":10,"path":11},"About Me","about-me","\u002Fabout-microbeonline-com\u002Fabout-me\u002F",{"title":13,"slug":14,"path":15},"Advertise with Us","advertise-us","\u002Fadvertise-us\u002F",{"title":17,"slug":18,"path":19},"Privacy Policy","privacy-policy","\u002Fprivacy-policy\u002F",{"title":21,"slug":22,"path":23},"Abbreviations","abbreviations","\u002Fabbreviations\u002F",{"title":25,"slug":26,"path":27},"Microbes","microbes","\u002Fmicrobes\u002F",{"title":29,"slug":30,"path":31},"Books","recommended-books","\u002Frecommended-books\u002F",{"type":33,"data":34},"blog",{"slug":35,"title":36,"description":37,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":40,"lastUpdatedDate":41,"draft":42,"category":43,"image":38,"body":44,"faq":45,"tags":55,"related":56},"interpretation-of-hepatitis-b-serologic-test-results","Hepatitis B Serology Interpretation: Reading the HBsAg\u002FAnti-HBc Panel","A step-by-step guide to reading HBsAg, anti-HBs, and anti-HBc panels, including the window period trap students consistently miss.",null,"Acharya Tankeshwar","2013-03-10","2026-07-01",false,"virology","A 28-year-old healthcare worker comes in for a routine occupational health screen. Her HBsAg is negative, her anti-HBs is negative, but her anti-HBc comes back positive. Is she infected? Immune? Should she be vaccinated again? Three results, and none of the clean textbook patterns fit. This is exactly the kind of result that trips up students and sometimes clinicians too, and the reason it's confusing isn't bad luck, it's that hepatitis B serology is fundamentally a timing problem, not a simple positive\u002Fnegative checklist.\n\nHere's the underlying rule that makes the whole panel readable: in any infection, antigen always appears before antibody, because antigen is the pathogen itself showing up, while antibody is the immune system's response to it, and a response always lags behind the thing it's responding to. So why design a test panel around three separate markers (HBsAg, anti-HBs, anti-HBc) instead of just one? Because each marker is reporting on a different moment in that timeline. HBsAg tells you the virus's antigen is present right now. Anti-HBs tells you the antibody response has caught up and won. Anti-HBc tells you an immune response was triggered at some point, full stop, without saying whether it's still winning, already won, or somewhere in between.\n\nThe healthcare worker's confusing result above has a name once you see it through this timing lens: the window period, a real, predictable gap between when HBsAg disappears and when anti-HBs has had time to rise high enough to detect. It's not a measurement error or a rare edge case; it's a direct, mechanical consequence of antibody production always trailing antigen clearance by some interval. Once you think of the three markers as snapshots taken at different points along one infection timeline rather than three independent yes\u002Fno tests, panels that look contradictory at first glance become predictable instead.\n\n### Viral Replication Markers\n\nMarkers of viral replication such as **HBeAg** and **HBV-DNA** (non-PCR method) are detectable during the early high replication phase but are not detectable during the later quiescent low replication phase. HBeAg is not a reliable marker of HBV replication when a **precore variant** is responsible for the infection. Such cases will be HBeAg negative, anti-HBe positive, but HBV-DNA (by a non-PCR method) positive.\n\nThe table below summarizes how these markers combine in different stages of infection or immunity; full definitions of each individual marker follow below the table.\n\n\u003Ctable style=\"min-width: 75px;\">\n\u003Ccolgroup>\u003Ccol style=\"min-width: 25px;\">\u003Ccol style=\"min-width: 25px;\">\u003Ccol style=\"min-width: 25px;\">\u003C\u002Fcolgroup>\u003Ctbody>\u003Ctr>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>Antigen\u002FAntibody tested\u003C\u002Fp>\u003C\u002Ftd>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>Test result\u003C\u002Fp>\u003C\u002Ftd>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>Inference\u003C\u002Fp>\u003C\u002Ftd>\u003C\u002Ftr>\u003Ctr>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>HBsAg\u003Cbr>anti-HBc\u003Cbr>anti-HBs\u003C\u002Fp>\u003C\u002Ftd>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>Negative\u003Cbr>Negative\u003Cbr>Negative\u003C\u002Fp>\u003C\u002Ftd>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>Susceptible\u003C\u002Fp>\u003C\u002Ftd>\u003C\u002Ftr>\u003Ctr>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>HBsAg\u003Cbr>anti-HBc\u003Cbr>anti-HBs\u003C\u002Fp>\u003C\u002Ftd>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>Negative\u003Cbr>Positive\u003Cbr>Positive\u003C\u002Fp>\u003C\u002Ftd>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>Immune due to natural infection\u003C\u002Fp>\u003C\u002Ftd>\u003C\u002Ftr>\u003Ctr>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>HBsAg\u003Cbr>anti-HBc\u003Cbr>anti-HBs\u003C\u002Fp>\u003C\u002Ftd>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>Negative\u003Cbr>Negative\u003Cbr>Positive\u003C\u002Fp>\u003C\u002Ftd>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>Immune due to hepatitis B vaccination\u003C\u002Fp>\u003C\u002Ftd>\u003C\u002Ftr>\u003Ctr>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>HBsAg\u003Cbr>anti-HBc\u003Cbr>IgM anti-HBc\u003Cbr>anti-HBs\u003C\u002Fp>\u003C\u002Ftd>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>Positive\u003Cbr>Positive\u003Cbr>Positive\u003Cbr>Negative\u003C\u002Fp>\u003C\u002Ftd>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>Acutely infected\u003C\u002Fp>\u003C\u002Ftd>\u003C\u002Ftr>\u003Ctr>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>HBsAg\u003C\u002Fp>\u003Cp>anti-HBc\u003C\u002Fp>\u003Cp>IgM anti-HBc\u003C\u002Fp>\u003Cp>anti-HBs\u003C\u002Fp>\u003C\u002Ftd>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>Positive\u003Cbr>Positive\u003Cbr>Negative\u003Cbr>Negative\u003C\u002Fp>\u003C\u002Ftd>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>Chronically infected\u003C\u002Fp>\u003C\u002Ftd>\u003C\u002Ftr>\u003Ctr>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>HBsAg\u003Cbr>anti-HBc\u003Cbr>anti-HBs\u003C\u002Fp>\u003C\u002Ftd>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>Negative\u003Cbr>Positive\u003Cbr>Negative\u003C\u002Fp>\u003C\u002Ftd>\u003Ctd colspan=\"1\" rowspan=\"1\">\u003Cp>Interpretation unclear; four possibilities:\u003C\u002Fp>\u003Cp>1.       Resolved infection (most common)\u003C\u002Fp>\u003Cp>2.       False-positive anti-HBc, thus susceptible\u003C\u002Fp>\u003Cp>3.       “Low level” chronic infection\u003C\u002Fp>\u003Cp>4.       Resolving acute infection\u003C\u002Fp>\u003C\u002Ftd>\u003C\u002Ftr>\u003C\u002Ftbody>\n\u003C\u002Ftable>\n\nTable source: CDC\n\n### How to Remember the Panel\n\n**Antigen first, antibody later, every time, because one is the cause and the other is the effect.** Whatever the infection, the pathogen's antigen always shows up before the antibody response to it, simply because the immune system can't respond to something that isn't there yet. Hepatitis B is no exception. HBsAg rises first; anti-HBs only appears once the body has cleared the virus. If you remember nothing else, remember that the antigen is the \"wanted poster\" and the antibody is the \"arrest,\" the arrest can only happen after the poster has been circulating for a while.\n\n**IgM means \"recent,\" IgG means \"past,\" because that's literally how the immune system upgrades its own response over time.** B cells initially produce IgM, then switch to producing IgG as the response matures, a process called class switching. So whenever an antibody's class is specified, IgM signals a recent event and IgG signals an older one, this applies as much to anti-HBc as it does to any other antibody you'll encounter in microbiology. When the class isn't specified, the test is reporting total antibody (IgG and IgM combined), so a \"positive anti-HBc\" alone doesn't tell you if the infection is recent or old until you specifically check the IgM fraction.\n\n**The window period, pictured as a relay handoff.** Picture two runners in a relay: HBsAg is the first runner, anti-HBs is the second. There's a brief stretch where the first runner has finished and let go of the baton, but the second runner hasn't gripped it yet, the baton (representing detectable evidence of the infection's status) is briefly \"in the air.\" During this gap, both HBsAg and anti-HBs test negative. Anti-HBc is the one marker that's reliably positive at this exact moment, because, unlike anti-HBs, it doesn't need to wait for the virus to be cleared first, it was triggered earlier in the infection by exposure to the core antigen and stays elevated throughout, completely independent of whether HBsAg or anti-HBs are currently up, down, or in between.\n\n**Why anti-HBs can be falsely \"negative\" twice over, for two completely different reasons.** In acute infection, anti-HBs is being produced but is invisibly bound up in antigen-antibody complexes, masked, not absent, because there's often still some HBsAg around for it to bind to. In chronic infection, it's bound to the much larger excess of circulating HBsAg instead, the same masking mechanism, but driven by a persistently high antigen load rather than a temporary one. Either way, \"anti-HBs negative\" doesn't always mean \"no anti-HBs being made,\" and this is worth remembering before concluding a chronic carrier has zero immune response at all.\n\n## Key Exam Facts\n\n| Marker | First detectable | Significance | Common pitfall |\n| --- | --- | --- | --- |\n| HBsAg | During incubation, before symptoms | Marks current infection (acute or chronic) | Persisting past 6 months = chronic, not just \"still acute\" |\n| Anti-HBc (total) | Onset of symptoms | Positive in all HBV infections, acute and chronic, lifelong | Doesn't distinguish recent vs. old infection on its own |\n| IgM anti-HBc | Onset of symptoms | Specifically marks recent (acute) infection | Disappears by \\~6 months; absence doesn't exclude past infection |\n| Anti-HBs | After HBsAg clears, or after vaccination | Marks recovery\u002Fimmunity | Can be falsely undetectable if bound in immune complexes |\n| HBeAg | During high-replication phase | Marks active replication\u002Fhigh infectivity | Unreliable in precore mutant infections |\n| Window period | Weeks between HBsAg clearance and anti-HBs rise | Anti-HBc is the only reliably positive marker | Often misread as \"no infection\" |\n\n**Hepatitis B surface antigen (HBsAg)**\n\nA protein on the surface of hepatitis B virus, it can be detected for serology test in high levels in serum during acute or chronic hepatitis B virus infection. The presence of HBsAg indicates that the person is infectious (see the \"Acutely infected\" and \"Chronically infected\" rows above). The body normally produces antibodies to HBsAg as part of the normal immune response to infection. *HBsAg is the antigen used to make hepatitis B vaccine.*\n\n**Hepatitis B surface antibody (anti-HBs)**\n\nThe presence of anti-HBs is generally interpreted as indicating recovery and immunity from hepatitis B virus infection (see the \"Immune due to natural infection\" and \"Immune due to hepatitis B vaccination\" rows above). Anti-HBs also develops in a person who has been successfully vaccinated against hepatitis B.\n\n**Total hepatitis B core antibody (anti-HBc)**\n\nAppears at the onset of symptoms in acute hepatitis B and persists for life. The presence of anti-HBc indicates previous or ongoing infection with hepatitis B virus in an undefined time frame (this is the marker that stays positive across the \"Acutely infected,\" \"Chronically infected,\" and ambiguous isolated-positive rows above).\n\n**IgM antibody to hepatitis B core antigen (IgM anti-HBc)**\n\nPositivity indicates recent infection with hepatitis B virus (see the \"Acutely infected\" row above). Its presence indicates acute infection.\n\n### Where Students Get Confused\n\n**Isolated anti-HBc positive (HBsAg negative, anti-HBs negative) is not automatically \"resolved infection.\"** This is the most commonly misread panel in the entire topic. The textbook table lists four possibilities for this exact combination, and \"resolved infection\" is the most common explanation, but it is not the only one. The window period itself produces this same pattern, and so can a false-positive anti-HBc result or a low-level chronic infection. The single isolated marker is never enough to confirm any of these; clinical context and repeat testing are what actually distinguish them.\n\n**HBeAg negative does not always mean \"not infectious.\"** In most patients, losing HBeAg and gaining anti-HBe signals declining viral replication and infectivity. But in patients infected with a precore variant strain, HBeAg can be negative and anti-HBe positive while HBV-DNA remains detectable by non-PCR methods, meaning the virus is still actively replicating despite an antigen profile that looks reassuring. This exception is a frequent exam trap precisely because it contradicts the \"normal\" HBeAg pattern students learn first.\n\n**A positive anti-HBs result doesn't always mean \"vaccinated, not infected.\"** Anti-HBs appears both after natural recovery and after successful vaccination. The marker that tells these two apart is anti-HBc: it's positive after natural infection and negative after vaccination alone. Anti-HBs positive without checking anti-HBc is an incomplete answer on its own.\n\n**References and further reading**\n\n1. Song, J. E., & Kim, D. Y. (2016). Diagnosis of hepatitis B. *Annals of Translational Medicine*, *4*(18), 338. \u003Chttps:\u002F\u002Fdoi.org\u002F10.21037\u002Fatm.2016.09.11>\n2. Kao, J. H. (2008). Diagnosis of hepatitis B virus infection through serological and virological markers. *Expert Review of Gastroenterology & Hepatology*, *2*(4), 553–562. \u003Chttps:\u002F\u002Fdoi.org\u002F10.1586\u002F17474124.2.4.553>",[46,49,52],{"question":47,"answer":48},"What does IgM anti-HBc tell us that HBsAg alone cannot?","IgM anti-HBc (IgM antibody to hepatitis B core antigen) is the most reliable serological marker of acute or recent HBV infection, providing two critical pieces of information that HBsAg alone cannot. First, it identifies acute infection: while HBsAg is positive in both acute and chronic infection, IgM anti-HBc is typically positive only in the first 6 months after infection — its presence confirms that the current HBsAg positivity represents a new, acute infection rather than chronic disease. Second, it bridges the diagnostic window period: in some patients with acute HBV, HBsAg is produced and then cleared by the immune response before anti-HBs appears, leaving a serological gap (the window period) where neither HBsAg nor anti-HBs is detectable. During this window period, IgM anti-HBc may be the only positive HBV marker — without it, an acutely infected patient in the window period would appear serologically negative. IgM anti-HBc is therefore particularly important in the differential diagnosis of acute hepatitis, where it can confirm HBV aetiology even when HBsAg has already cleared.",{"question":50,"answer":51},"What is the precore mutant variant of HBV and why does it complicate the interpretation of HBeAg results?","The hepatitis B precore mutant is a variant of HBV in which a point mutation (G1896A) in the precore region of the viral genome introduces a premature stop codon, preventing translation of the HBeAg protein. Despite this mutation, the virus continues to replicate actively and can cause significant liver disease. Patients infected with precore mutants are HBeAg negative and anti-HBe positive — the serological pattern that normally indicates low replication and reduced infectivity. However, because the HBeAg-negative\u002Fanti-HBe positive status in these patients is due to a viral mutation rather than genuine immune control, HBV DNA levels by PCR remain elevated (often >2,000 IU\u002FmL and sometimes >20,000 IU\u002FmL), liver inflammation is active, and the patient remains at risk for cirrhosis and hepatocellular carcinoma. This is why HBV DNA quantification by PCR is mandatory in all HBeAg-negative chronic HBV patients — relying on HBeAg\u002Fanti-HBe serology alone to determine disease activity would miss active liver disease in patients with precore mutant infection. Precore mutants are prevalent in Mediterranean countries, the Middle East, South Asia, and Africa.",{"question":53,"answer":54},"Why does successful hepatitis B vaccination produce anti-HBs without anti-HBc?","The hepatitis B vaccine contains only purified recombinant hepatitis B surface antigen (HBsAg) — the outer envelope protein of the virus. When administered, it stimulates the immune system to produce antibodies specifically against HBsAg (anti-HBs), which are the protective antibodies that prevent future HBV infection. Because the vaccine contains no core antigen (HBcAg), no polymerase antigen, and no live or inactivated virus, there is no stimulus for the production of antibodies against core antigen (anti-HBc). This is the critical serological distinction between vaccine-induced immunity and naturally acquired immunity from past infection: vaccination produces isolated anti-HBs without anti-HBc, while natural infection (even if resolved) produces both anti-HBs and anti-HBc. This distinction has practical clinical importance: when evaluating an individual's HBV immune status, a laboratory result showing anti-HBs positive with anti-HBc negative confirms that immunity is vaccine-derived and the person has never been infected. Anti-HBs positive with anti-HBc positive indicates past natural infection and immunity — the same protective anti-HBs level but a different history. Understanding this prevents misclassification of previously infected individuals as simply vaccinated.",[],[],[58,64,71,76,80,84,89,94,98,102],{"slug":59,"name":39,"description":60,"image":61,"body":62,"postCount":63},"acharya-tankeshwar","Editor-in-chief","https:\u002F\u002Fassets.microbeonline.com\u002Fauthors\u002Ftankeshwar-acharya-author-microbeonline.jpg","***Tankeshwar Acharya, MSc (Medical Microbiology)***\n\n*Tankeshwar Acharya is an Assistant Professor in the Department of Microbiology at Patan Academy of Health Sciences (PAHS), Nepal, where he has been teaching and practicing clinical microbiology for over 14 years. He is the founder of Microbe Online, one of the leading free microbiology education resources on the web, covering bacteriology, mycology, parasitology, immunology, and clinical laboratory diagnostics written from direct experience in both the classroom and the diagnostic laboratory.*",433,{"slug":65,"name":66,"description":67,"image":68,"body":69,"postCount":70},"ashma-shrestha","Ashma Shrestha","SEO Copywriter and Science Communicator\nKathmandu, Nepal","https:\u002F\u002Fassets.microbeonline.com\u002Fauthors\u002Fashma-shrestha.png","Ashma Shrestha holds a Master of Science in Medical Microbiology from the Institute of Science and Technology (IOST), Tribhuvan University, Nepal, where she developed a strong foundation in virology, molecular biology, and diagnostic microbiology.\n\nShe now works as an SEO Copywriter at Resolution Digital, where she combines her scientific training with research-driven content strategy. She is certified in Google Analytics and Google Business Profile (GBP), and brings a data-informed approach to science communication writing content that is not only accurate but structured to reach and serve the students who need it most.\n\nAt microbeonline, Ashma contributes articles primarily in virology and molecular biology, areas she finds most compelling for their mechanistic depth and their growing clinical relevance. Her writing reflects the same standard the site is built on: factual rigor, clear explanation of the *why* behind microbiology concepts, and content that helps students move from memorization to genuine understanding.\n\nShe is passionate about making complex microbiological concepts accessible without sacrificing accuracy; a skill that sits at the intersection of her scientific training and her professional work in content and SEO.",81,{"slug":72,"name":73,"description":74,"image":38,"body":38,"postCount":75},"sushmita-baniya","Sushmita Baniya","Author \u002F Contributor",32,{"slug":77,"name":78,"description":74,"image":38,"body":38,"postCount":79},"samikshya-acharya","Samikshya Acharya",20,{"slug":81,"name":82,"description":74,"image":38,"body":38,"postCount":83},"alisha-tripathi","Alisha Tripathi",6,{"slug":85,"name":86,"description":87,"image":38,"body":38,"postCount":88},"aastha-shrestha","Aastha Shrestha"," Author \u002F Contributor",10,{"slug":90,"name":91,"description":92,"image":38,"body":38,"postCount":93},"guest-author","Guest Author","Guest Author \u002F Contributor",2,{"slug":95,"name":96,"description":74,"image":38,"body":38,"postCount":97},"srijana-khanal","Srijana Khanal",18,{"slug":99,"name":100,"description":92,"image":38,"body":38,"postCount":101},"dr-poonam-acharya","Dr. Poonam Acharya",1,{"slug":103,"name":104,"description":74,"image":38,"body":105,"postCount":106},"nisha-rijal","Nisha Rijal","**Nisha Rijal** is a microbiologist and quality assurance specialist. She served for nearly 12 years as a microbiologist at the National Public Health Laboratory (NPHL), Nepal's national reference laboratory, and continues to work as a consultant microbiologist in international public health organization. ",51]